The AVMXF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AVMXF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AVMXF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AVMXF Detailed Price Forecast - CNN Money||View AVMXF Detailed Summary - Google Finance|
|View AVMXF Detailed Summary - Yahoo! Finance||View AVMXF Stock Research & Analysis - Zacks.com|
|View AVMXF Trends & Analysis - Trade-Ideas||View AVMXF Major Holders - Barrons|
|View AVMXF Call Transcripts - NASDAQ||View AVMXF Breaking News & Analysis - Seeking Alpha|
|View AVMXF Annual Report - CompanySpotlight.com||View AVMXF OTC Short Report - OTCShortReport.com|
|View AVMXF Fundamentals - TradeKing||View AVMXF SEC Filings - Bar Chart|
|View Historical Prices for AVMXF - The WSJ||View Performance/Total Return for AVMXF - Morningstar|
|View the Analyst Estimates for AVMXF - MarketWatch||View the Earnings History for AVMXF - CNBC|
|View the AVMXF Earnings - StockMarketWatch||View AVMXF Buy or Sell Recommendations - MacroAxis|
|View the AVMXF Bullish Patterns - American Bulls||View AVMXF Short Pain Metrics - ShortPainBot.com|
|View AVMXF Stock Mentions - StockTwits||View AVMXF Stock Mentions - PennyStockTweets|
|View AVMXF Stock Mentions - Twitter||View AVMXF Investment Forum News - Investor Hub|
|View AVMXF Stock Mentions - Yahoo! Message Board||View AVMXF Stock Mentions - Seeking Alpha|
|View Insider Transactions for AVMXF - SECform4.com||View Insider Transactions for AVMXF - Insider Cow|
|View AVMXF Major Holdings Summary - CNBC||View Insider Disclosure for AVMXF - OTC Markets|
|View Insider Transactions for AVMXF - Yahoo! Finance||View Institutional Holdings for AVMXF - NASDAQ|
|View AVMXF Stock Insight & Charts - FinViz.com||View AVMXF Investment Charts - StockCharts.com|
|View AVMXF Stock Overview & Charts - BarChart||View AVMXF User Generated Charts - Trading View|
AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that key opinion leaders from five U.S. burn centers presented clinical results of the RECELL® Autologous Cell Harvesting Device (RECELL® System) at two U.S. burn conferences, the 31st Annual Southern Region Burn CME Conference held in Mobile, AL and the Northeast Region Burn Conference held in Cambridge, MA. In addition, the burn surgeons led two medical education symposiums on the use of the RECELL System at the conferences.
Avita Medical First Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update
Posted on Tuesday October 30, 2018
AVITA Medical Announces Commencement of Randomized Controlled Clinical Study of RECELL® System in Treatment of Children with Burn Injuries
Posted on Wednesday October 24, 2018
AVITA Medical (ASX: AVH) (OTCQX: AVMXY), a global regenerative medicine company, today announced that the commencement of a randomized, controlled clinical study of the RECELL® Autologous Cell Harvesting Device (RECELL® System) in the treatment of significant superficial partial- and mid-thickness pediatric burns, including scald injuries. The clinical trial is being conducted by the Queensland University of Technology (QUT) in collaboration with the Pegg Leditschke Children’s Burns Centre at Lady Cilento Children’s Hospital in Brisbane, QLD.
AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement of Commercial Shipping
Posted on Wednesday October 17, 2018
AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has received the first commercial sales orders from U.S. burn centers for the RECELL® Autologous Cell Harvesting Device (RECELL® System) and has commenced commercial shipment of the product. The U.S. Food and Drug Administration (FDA) approved on 20 September 2018 the RECELL System to treat acute thermal burns in patients 18 years and older.